Joshua Muia on Genetic Alterations Affecting ADAMTS13 Maturation at IPS 2025
Joshua Muia, Associate Investigator at Versiti Blood Research Institute, shared on LinkedIn:
”It was an exciting week presenting work from laboratory at the International Proteolysis Society’s 13th Biannual Meeting in Buzios, Rio de Janeiro, Brazil.”
The International Proteolysis Society’s 13th Biannual Meeting , held in Búzios, Brazil, from October 26–30, 2025, offered an excellent opportunity for scholars and researchers to gather and engage in meaningful discussions on a wide range of topics.
The meeting also served as a valuable platform for networking and building important professional connections within the research community.
At the meeting Joshua Muia presented research from the Versiti Blood Research Institute laboratory on genetic alterations affecting ADAMTS13 maturation.

Stay updated with Hemostasis Today.
-
Nov 8, 2026, 12:22Marc Carrier: Advancing Catheter-Related Thrombosis Prevention Through Factor XI Inhibition
-
Nov 8, 2026, 11:56Why Genetic Predisposition Does Not Always Lead to Thrombosis – Stork Genetics
-
Nov 8, 2026, 11:45Sher-Lu Pai: Investigating Intracardiac Thrombosis and Its Management in Liver Transplantation
-
Nov 8, 2026, 11:25Mehmet Cilingiroglu: Navigating Anticoagulation Choices in Acute Coronary Syndrome PCI
-
Nov 8, 2026, 07:16Gilberto de lima Lopes Junior: The Cardiovascular Consequences of Cancer in Younger Patients
-
Nov 8, 2026, 06:51Haney Mallemat: Key Principles and Pitfalls of LVAD Emergencies
-
Nov 8, 2026, 06:31Maria Omer: Clinical Recognition and Management of Cavernous Sinus Thrombosis
-
Nov 8, 2026, 06:16Natasha Jolakoski: University of New Mexico Hospital Promotes PGY-2 Thrombosis and Hemostasis Management Pharmacy Residency
-
Nov 8, 2026, 05:47Safaa Hilal: POCUS in the Evaluation of Perioperative Troponin Elevation